An extended statistical analysis, including logistic regression (Table 2) and ROC analysis (Figure 3), was carried out in order to evaluate the clinical value of the KLK5 expression down-regulation for the prediction of breast cancer and its discrimination from non-cancer breast lesions in tissue biopsies. This evidence concerns the gene KLK5 and breast carcinoma.